We would like to inform sponsors, CRO representatives, and monitors that the Opinion of SÚKL´s Department of Clinical Trials of Medicinal Products on ongoing clinical trials and pending clinical trials related to COVID-19 from 22 December 2020 will expire on
30 June 2021. Sponsors should return to the standard regime and should no longer apply for the emergency measures permitted by this statement.
11 June 2021
Department of Clinical Trials of Medicinal Products